GO
Loading...

Merck suffering through generic competition: Expert

Monday, 28 Oct 2013 | 7:47 AM ET

Barbara Ryan, FTI Consulting managing director, breaks down the pharmaceutical company's earnings and weighs in on two promising drugs in the pipeline, as the company ramps up research and development.